NCT02588287View on ClinicalTrials.gov

Effects of Sofosbuvir/Ledipasvir Treatment on the Pharmacokinetics and Renal Safety of Tenofovir

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Hepatitis C and HIV Coinfection
Interventions
OTHER

Blood draws for tenofovir PK, renal function

Trial Locations (1)

80045

University of Colorado Hospital, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT02588287 - Effects of Sofosbuvir/Ledipasvir Treatment on the Pharmacokinetics and Renal Safety of Tenofovir | Biotech Hunter | Biotech Hunter